NCT04924998View on ClinicalTrials.gov

Clinical Study for AL-CM

RecruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

June 1, 2031

Study Completion Date

June 1, 2031

Conditions
Immunoglobulin Light Amyloidosis Cardiomyopathy
Interventions
DRUG

current treatment of AL-CM

current treatment of AL-CM

Trial Locations (1)

Unknown

RECRUITING

2nd Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER